DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,684,221 | -3.7% | 6,788 | -6.7% | 0.13% | -1.5% |
| Q2 2023 | $1,749,026 | -5.1% | 7,279 | -0.3% | 0.13% | -7.0% |
| Q1 2023 | $1,842,942 | -3.5% | 7,304 | +1.6% | 0.14% | -7.7% |
| Q4 2022 | $1,910,760 | +15.0% | 7,192 | +11.9% | 0.16% | -1.9% |
| Q3 2022 | $1,661,000 | +3.5% | 6,426 | +1.6% | 0.16% | +16.2% |
| Q2 2022 | $1,605,000 | -19.7% | 6,323 | -7.1% | 0.14% | -7.5% |
| Q1 2022 | $1,999,000 | -4.3% | 6,809 | +7.4% | 0.15% | +23.5% |
| Q4 2021 | $2,088,000 | +18.6% | 6,341 | +9.8% | 0.12% | +11.2% |
| Q3 2021 | $1,760,000 | +18.0% | 5,776 | +4.0% | 0.11% | +15.1% |
| Q2 2021 | $1,492,000 | +28.4% | 5,556 | +7.7% | 0.09% | +13.4% |
| Q1 2021 | $1,162,000 | -11.2% | 5,157 | -12.3% | 0.08% | -16.3% |
| Q4 2020 | $1,308,000 | +19.1% | 5,882 | +15.4% | 0.10% | +2.1% |
| Q3 2020 | $1,098,000 | +21.6% | 5,096 | -0.1% | 0.10% | +9.1% |
| Q2 2020 | $903,000 | +26.5% | 5,100 | -1.0% | 0.09% | +11.4% |
| Q1 2020 | $714,000 | +4.5% | 5,150 | +15.9% | 0.08% | +16.2% |
| Q4 2019 | $683,000 | +556.7% | 4,444 | +518.1% | 0.07% | +161.5% |
| Q3 2019 | $104,000 | -80.3% | 719 | -80.5% | 0.03% | -50.9% |
| Q2 2019 | $528,000 | +20.5% | 3,695 | +11.4% | 0.05% | +17.8% |
| Q1 2019 | $438,000 | +73.8% | 3,318 | +36.0% | 0.04% | +50.0% |
| Q4 2018 | $252,000 | +157.1% | 2,440 | +172.0% | 0.03% | +7.1% |
| Q3 2018 | $98,000 | – | 897 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |